SynchNeuro is a Portfolio Company of Boomerang Ventures INDIANAPOLIS, IN / ACCESS Newswire / November 12, 2025 / Boomerang ...

Cognision, provider of advanced neurobiomarker technology, announces its partnership with Kynexis to utilize the COGNISION(R) System in Kynexis' Phase 2 clinical trial of KYN-5356 in subjects with ...

Cognision, provider of advanced neurobiomarker technology, announces its partnership with Kynexis to utilize the COGNISION® System in Kynexis' Phase 2 clinical trial of KYN-5356 in subjects with ...

The U.S. Brain Monitoring Systems Market is entering a transformative decade as demand surges for advanced neurodiagnostic ...

Beacon Biosignals has secured $86m in a Series B funding round aimed at expanding its neurodiagnostic dataset and furthering ...

Staci Marklin, whose doctor told her that developing early-onset dementia was unlikely, says some people don't believe her ...

A: Consumer devices typically infer sleep from heart rate or movement, while clinical sleep monitoring directly measures brain function. Beacon Biosignals delivers gold-standard EEG and ...

A hidden sleep switch in the brain triggers a sharp tipping point about four minutes before standard sleep onset.

Staci Marklin thought running around after her toddler was sapping her physical and mental energy-but in reality, the 46-year ...

With its new investment, Beacon plans to scale its technology and operations. It aims to accelerate neurobiomarker discovery ...

Emilie Sime, now one, from Uddingston, South Lanarkshire, underwent surgery and then received months of chemotherapy.